Peptimes

Medical Disclaimer

Version française (Canada)

Effective date: November 12, 2026

Peptimes isn’t available in app stores yet. This disclaimer describes the app as it will work at launch.

In an emergency

Peptimes isn’t for emergencies. Get help first; don’t use the app to decide what to do.

  • Trouble breathing, chest pain, fainting, a seizure, a severe allergic reaction, or any other emergency: call 911, or your local emergency number.
  • You took too much, the wrong thing, or a dose by mistake, with no emergency signs: call Poison Control at 1-800-222-1222 (US, free, 24 hours). They’ll tell you whether you need emergency care.
  • If you’re thinking about harming yourself: call or text 988, the Suicide & Crisis Lifeline (US).
  • Outside the US: the Poison Control and 988 numbers above are for the US. Call your local emergency number, poison centre or crisis line instead. For example:
    • EU and EEA: 112.
    • UK: 999 or 112 in an emergency; NHS 111 for urgent advice.
    • Canada: 911; your provincial poison centre; call or text 988 for suicide crisis support.
    • Australia: 000; Poisons Information Centre 13 11 26; Lifeline 13 11 14.
    • New Zealand: 111; National Poisons Centre 0800 764 766.
    • India: 112.

1. Peptimes isn’t medical advice

  • What it is: a personal record-keeping and reference app.
  • What it isn’t: nothing in it is medical advice, a diagnosis or a treatment recommendation. That includes the Library, Estimated Levels and other Insights, the Doctor report, Vial Inventory, Create a blend, the Calculator (on Android), reminders, the widget, badges, milestones, the Progress Jar and goals, readings from Apple Health or Health Connect, and our help center.
  • No clinical relationship: using Peptimes, or contacting us, doesn’t create a doctor–patient or any other professional relationship. Nobody at Peptimes is your healthcare provider.

Talk to a licensed clinician before starting, stopping, changing or combining any medicine, peptide, hormone or supplement. Never ignore professional advice, or delay seeking it, because of something you saw in Peptimes.

What Peptimes is for: keeping your own records, and general reference. It isn’t intended to diagnose any condition or to guide treatment decisions.

Peptimes isn’t FDA-cleared or approved, and isn’t intended to be a medical device.

Badges, milestones and the Progress Jar count what you’ve logged. They celebrate record-keeping, not any medicine, and don’t mean a compound is working or safe.

2. Peptimes records what you enter, and doesn’t check it

What it records: the compounds, amounts, times, routes, injection sites, side effects, feelings (including hunger and food noise) and notes you enter, the vials you add, and the compounds you name yourself.

What it doesn’t do:

  • check whether your entries are correct, safe or right for you;
  • check for interactions or contraindications;
  • tell you what to do about a missed dose. It can remind you about a dose you haven’t logged, and that’s all.

Where the app says so: Log a Dose and the schedule sheet show “Not medical advice. Peptimes doesn’t recommend doses.” Vial Inventory says what’s left is “your own record, not a measurement or advice”. A compound you add yourself shows that Peptimes has no information about it.

3. Reminders and the widget

Reminders and the Home Screen widget (iPhone) are conveniences, not a medical safety system. Reminders may not arrive, and the widget may not be current (Terms §7). Don’t rely on Peptimes alone to remember a medicine.

4. The Library

What it is: a summary of publicly available sources on 200+ compounds: FDA labels, clinical-trial registries, regulatory notices and published studies.

Its limits:

  • It may be incomplete, out of date or wrong. Regulatory and anti-doping rules change often. Check the FDA, the label for your product, and the current WADA Prohibited List.
  • The dose, frequency and route lines aren’t recommendations. They show what a label or a study says, for that product or study:
    • “Label: …” is what an approved product’s label says, for that product and its approved uses;
    • “Studied: … (trial doses, not a recommendation)” is what research used, often in small, short or animal studies;
    • “No established human dose” means none has been established;
    • the Frequency and Route lines describe the same label or studies.
    • None of these is a dose, schedule or course length for you.
  • “What studies found” summarizes research findings. It isn’t a claim that a compound works or is safe for you.
  • The Evidence Rating (1/5 “Theoretical Only” to 5/5 “FDA Approved”) describes how much research exists. It isn’t a safety score.
  • Status labels are a snapshot from our last review of the Library:
    • FDA Approved: an FDA-approved product exists for at least one use. The entry says which.
    • Not FDA-Approved: no FDA-approved product exists. Its safety and effectiveness in people haven’t been established.
    • Approved outside the US: approved by another country’s regulator, not the FDA.
    • Phase 1 / 2 / 3 Trials: investigational, in clinical trials, not approved.
    • Dietary Supplement: sold as a supplement, not an approved drug.
    • Compoundable: what the FDA’s compounding lists allowed at the time of review.
    • Compounding Restricted: the FDA listed the substance in Category 2 of its compounding lists (bulk substances that may present significant safety risks) at the time of review.
    • Status can differ by product and by country.
    • They describe the US (the FDA), except “Approved outside the US”. Where you live, a compound may need a prescription, or be banned. Check your own country’s medicines regulator.
  • Compounded medicines aren’t FDA-approved, even when they contain the same active ingredient as an approved medicine.
  • Controlled substances: the Library marks its testosterone products as Schedule III controlled substances that need a prescription. Other listed compounds can also be controlled, in the US or where you live, so check before you use, buy or travel with any compound.
  • Anti-doping: the WADA Status row shows “Prohibited” (or “Prohibited (WADA S0)” for substances no health authority has approved for human use) where the Library has a record of it, and otherwise “Check the WADA list”. “Check the WADA list” doesn’t mean a compound is allowed.
  • No sale or endorsement: Peptimes doesn’t sell or endorse any product, and can’t verify any product’s identity, purity or strength. Products sold online, including those labeled “research use only”, may be counterfeit, contaminated or mislabeled.
  • Brand names are trademarks of their owners. Peptimes isn’t affiliated with or endorsed by them.

Compounds you add yourself have no Library page. Peptimes knows only the name and unit you gave.

5. Features available only on Android

Some features are available only in the Android version of Peptimes; their terms are shown in that app.

6. Estimated levels (Insights)

What it shows: for five compounds (semaglutide by injection, tirzepatide, dulaglutide, liraglutide and retatrutide), Insights can show an estimated amount of the compound in your body, in mg or mcg, including an estimate for now (“Now · ≈ …”). It isn’t a measurement and isn’t a blood level.

How it’s calculated (disclosed under Apple Guideline 1.4.1):

  • The model: the standard one-compartment model with first-order absorption, computed on your phone. Each dose’s absorbed share is taken up at a rate set so the curve peaks at the time to peak below, and cleared at the half-life below. For semaglutide and dulaglutide the time to peak was measured at steady state on weekly doses, and the curve is fitted to that.
  • Blends: each compound is estimated on its own. Amounts of different compounds are never added together.
  • After now: only the doses you’ve recorded. No future doses are assumed.
Compound Half-life Time to peak Share of each dose absorbed Sources
Semaglutide (injection) 168 hours (about 1 week) 30 hours, at steady state on weekly doses 89% Ozempic Prescribing Information (rev. 05/2026) §12.3; Wegovy Prescribing Information (rev. 06/2026) §12.3; time to peak: Shi A et al., Adv Ther 2021 (PMID 33159658)
Tirzepatide 120 hours (about 5 days) 24 hours 80% Mounjaro Prescribing Information (rev. 08/2026) §12.3; time to peak: FDA Clinical Pharmacology Review, NDA 215866. Zepbound’s label gives 5–6 days; recorded, not used
Dulaglutide 120 hours (about 5 days) 48 hours, at steady state on weekly doses 65% for doses of 0.75 mg or less; 47% above Trulicity Prescribing Information (rev. 03/2026) §12.3
Liraglutide 13 hours 11 hours 55% Saxenda Prescribing Information (rev. 02/2026) §12.3; Victoza Prescribing Information (rev. 10/2025) §12.3
Retatrutide 144 hours (about 6 days) Assumed: 24 hours Assumed: 100% Half-life: Urva S et al., Lancet 2022 (PMID 36354040). Time to peak and absorption aren’t published

Retatrutide isn’t approved, so its absorption isn’t published. Peptimes assumes all of each dose is absorbed and peaks a day after it, and the chart says so.

Which of your doses are used:

  • your recorded doses, at their recorded times;
  • a dose with a day but no time is placed at the time it was scheduled for that day, and the chart says so; with no scheduled time either, it’s left out;
  • a dose without a readable amount and unit is left out;
  • semaglutide: only doses recorded as injections (by route or injection site) are used, because it also comes as a tablet. Doses logged by mouth, or saved with no route and no site, are left out, and the chart says how many;
  • a dose dated later is included once its time arrives;
  • IU: if any dose of a compound is recorded in IU, no estimate is shown for that compound;
  • compounds you added yourself are never estimated.

When a compound gets no chart: if another compound has a chart, the card lists it as “not offered yet”; if no compound has a chart, there’s no Estimated Levels card.

Its limits:

  • Real levels can differ substantially. Body size, kidney and liver function, injection technique, the product’s actual content and other factors matter, and the estimate is only as complete as your records.
  • It doesn’t show whether a compound is working or is safe. A lower estimate doesn’t mean the effects have ended, or that another dose is safe.
  • Never use it to start, stop, increase, decrease or time a dose.

7. Your records, readings and reports

  • Injection Sites shows where you recorded injecting. It doesn’t advise where to inject next; follow your clinician and your product’s label.
  • Weight Change by Dose, How You’ve Been Feeling (energy, mood, sleep, hunger and food noise), Side Effects and Dose History show your own records over time. They don’t show what caused a change.
  • Vial Inventory works out what’s left only from the amount you entered and the doses you counted against the vial. It isn’t a measurement, and it doesn’t tell you when a product expires or should be replaced.
  • Readings from Apple Health or Health Connect (such as sleep, resting heart rate, heart rate variability, body fat, waist, steps, nutrition and workouts) come from other apps and devices. Peptimes doesn’t check them. They aren’t medical measurements.
  • The Doctor report summarises what you entered, for the period you pick. Peptimes doesn’t check it. Its “logged” and “not logged” counts are worked out from your own schedules and logs. It leaves out notes, injection sites and estimated levels. It isn’t a medical record, and it isn’t medical advice. Tell your clinician how it was made.
  • Side effects: tell your clinician about any side effect that worries you. You can also report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

8. Your responsibility

You’re responsible for your decisions about what you take and how, for following your prescriptions and the law where you live, and for checking information before relying on it. You use Peptimes at your own risk.

8A. Outside the United States

  • The Library describes the US. An “FDA Approved” label means the US Food and Drug Administration approved a product for at least one use. It doesn’t mean your country’s medicines regulator has approved it. A compound approved in the US may need a prescription, be unapproved, or be banned where you live. Check your own country’s medicines regulator.
  • Peptimes doesn’t advertise or promote any medicine. The Library is general reference information. It doesn’t recommend, sell or link to any product, and nothing in it is an offer or an invitation to buy or use one.
  • Peptimes isn’t intended to be a medical device. It’s intended for keeping your own records and for general reference, not to diagnose, prevent, monitor, treat or predict any disease, or to work out a dose.
  • Reporting side effects. Outside the US, report side effects to your doctor or pharmacist, or to your country’s medicines regulator: for example the MHRA’s Yellow Card scheme in the UK, your national medicines authority in the EU, Health Canada (MedEffect), the TGA in Australia, or Medsafe in New Zealand.

9. Contact

PT Development LLC, doing business as Peptimes · 30 N Gould St #71196, Sheridan, WY 82801, United States · legal@peptimes.com